Biotecnología
Biotecnología
Arranta Bio Expands RNA Process Development Capacity by 50%
10/03/2023 -
The expansion includes a state-of-the-art laboratory space with flexible, modular small scale and pilot scale equipment.
Evonik Opens New Facility for Pharmaceutical Lipids in Germany
10/03/2023 -
The types of lipids that can be produced at the facility will serve a broad range of RNA and gene therapies.
Korro Bio, Genevant to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency
08/03/2023 -
Collaboration to combine Korro’s RNA editing technology and Genevant’s LNP technology.
Aji Bio-Pharma Develops Highly Functional Ancestral RNA Ligase
02/03/2023 -
New enzyme for double strand oligonucleotide formation with high productivity.
GenScript ProBio, RVAC Medicines Enter GMP Plasmid DNA Manufacturing Pact
02/03/2023 -
Alliance will enable GenScript ProBio to accelerate its clinical manufacturing of mRNA-based COVID-19 vaccine, RVM-V001.
CPG Sec. 400.210, Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs
02/03/2023 -
CPG Sec. 400.210, Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs
FDA Approves Sanofi’s Once-weekly ALTUVIIIO for Hemophilia A
02/03/2023 -
Represents a new class of factor VIII therapy for hemophilia A that offers significant bleed protection.
Porton Advanced, Yinjia Biosciences Partner to Enhance CDMO Technology Platform
02/03/2023 -
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
Polyplus Strengthens CGT Production Capabilities
02/03/2023 -
Announces GMP accreditation for DNA production at Xpress Biologics’ Belgian facility.
Touchlight Cleared by FDA for IND Utilizing Doggybone DNA
02/03/2023 -
Major landmark demonstrates the clinical adoption of Touchlight's proprietary technology across modalities.
AcuraBio Expands cGMP Plasmid DNA, CDMO Services with Cytiva's Single-Use Purification Technology
15/02/2023 -
The new protocol features single-use purification technology which aims to deliver efficiency, high purity level outcome and sustainable process.
Element Biosciences, Bio-Rad Partner to Deliver Seamless Sequencing
15/02/2023 -
The SEQuoia Express Stranded RNA Library Prep Kit offers the additional benefit of an efficient 3-tube workflow for detection of long RNAs.
BioNTech SE Completes Plasmid DNA Manufacturing Facility in Marburg, Germany
03/02/2023 -
Will independently manufacture the majority of its own current regular demand for DNA plasmids in the new manufacturing facility.
Catalent Opens Manufacturing Facility for Cell Therapies
31/01/2023 -
Completes commercial-scale plasmid DNA manufacturing site in Gosselies, Belgium.
Forecyte Bio Opens CGT Production Facility in Maryland
18/01/2023 -
cGMP production suites in Frederick, MD are for plasmid DNA, viral vector and cell therapy production.
ProBioGen, Boehringer Partner on DirectedLuck Transposase Technology
11/01/2023 -
Achieves high protein expression and maximum stability, reducing time and manual lab work for selecting superior clones for best titers and product quality.
Nykode Therapeutics and Richter-Helm BioLogics Enter Manufacturing Partnership
04/01/2023 -
Richter-Helm to supply plasmid DNA for Nykode’s portfolio.
Reaction Biology Selected for Specialized Center in Chemical Biology Consortium
21/12/2022 -
Project includes developing a robust SPR assay to measure the binding affinity of small molecules to human target proteins.
AGC Biologics, Gore Partner on Purification & Mfg. Services for Antibodies
14/12/2022 -
Protein Capture Devices and development and manufacturing platforms aim to advance downstream purification and manufacturing.
Empresarios del cannabis europeos piden a la Comisión Europea que permita la legalización
13/12/2022 -
canamo.net/ - Un grupo de 20 empresas del sector del cannabis en Europa han enviado una carta a la Comisión Europea para solicitar que valore la propuesta de Alemania de legalizar el...
Blood & Blood Products
13/12/2022 -
CBER regulates the collection of blood and blood components used for transfusion or for the manufacture of pharmaceuticals derived from blood and blood components. FDA has strengthened the...
